Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | March 02, 2023 09:06am

Gainers

  • Biophytis (NASDAQ:BPTS) stock moved upwards by 34.1% to $0.56 during Thursday's pre-market session. The company's market cap stands at $11.4 million.
  • OncoSec Medical (NASDAQ:ONCS) shares rose 32.35% to $2.7. The market value of their outstanding shares is at $8.0 million.
  • Avenue Therapeutics (NASDAQ:ATXI) stock increased by 30.35% to $1.46. The market value of their outstanding shares is at $8.0 million.
  • BioRestorative Therapies (NASDAQ:BRTX) shares increased by 26.52% to $3.53. The company's market cap stands at $12.9 million.
  • Apexigen (NASDAQ:APGN) shares rose 10.46% to $0.95. The company's market cap stands at $23.4 million.
  • Chimerix (NASDAQ:CMRX) shares increased by 9.96% to $1.75. The company's market cap stands at $153.9 million. The company's, Q4 earnings came out today.

Losers

  • Genelux (NASDAQ:GNLX) stock fell 19.5% to $13.6 during Thursday's pre-market session. The market value of their outstanding shares is at $320.5 million.
  • Cano Health (NYSE:CANO) stock fell 18.48% to $1.28. The market value of their outstanding shares is at $306.1 million. As per the news, the Q4 earnings report came out yesterday.
  • Xenetic Biosciences (NASDAQ:XBIO) stock fell 11.77% to $0.45. The market value of their outstanding shares is at $6.8 million.
  • Lucira Health (NASDAQ:LHDX) shares declined by 11.66% to $0.7. The market value of their outstanding shares is at $28.3 million.
  • Ontrak (NASDAQ:OTRK) shares decreased by 11.31% to $0.55. The market value of their outstanding shares is at $15.0 million.
  • Celularity (NASDAQ:CELU) shares declined by 10.44% to $0.65. The market value of their outstanding shares is at $94.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: APGN ATXI BPTS BRTX CANO CELU CMRX GNLX LHDX ONCS OTRK XBIO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist